Characterization of chemokines and their receptors in the central nervous system: physiopathological implications

被引:255
作者
Bajetto, A
Bonavia, R
Barbero, S
Schettini, G
机构
[1] Adv Biotechnol Ctr, Inst Canc Res, Serv Pharmacol & Neurosci, I-16132 Genoa, Italy
[2] Univ Genoa, Dept Oncol Biol & Genet, Pharmacol Sect, Genoa, Italy
关键词
acquired immune deficiency syndrome dementia complex; Alzheimer's disease; brain tumors; chemokines; multiple sclerosis; stroke;
D O I
10.1046/j.1471-4159.2002.01091.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chemokines represent key factors in the outburst of the immune response, by activating and directing the leukocyte traffic, both in lymphopoiesis and in immune surveillance. Neurobiologists took little interest in chemokines for many years, until their link to acquired immune deficiency syndrome-associated dementia became established, and thus their importance in this field has been neglected. Nevertheless, the body of data on their expression and role in the CNS has grown in the past few years, along with a new vision of brain as an immunologically competent and active organ. A large number of chemokines and chemokine receptors are expressed in neurons, astrocytes, microglia and oligodendrocytes, either constitutively or induced by inflammatory mediators. They are involved in many neuropathological processes in which an inflammatory state persists, as well as in brain tumor progression and metastasis. Moreover, there is evidence for a crucial role of CNS chemokines under physiological conditions, similar to well known functions in the immune system, such as proliferation and developmental patterning, but also peculiar to the CNS, such as regulation of neural transmission, plasticity and survival.
引用
收藏
页码:1311 / 1329
页数:19
相关论文
共 203 条
[1]   The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques [J].
Abi-Younes, S ;
Sauty, A ;
Mach, F ;
Sukhova, GK ;
Libby, P ;
Luster, AD .
CIRCULATION RESEARCH, 2000, 86 (02) :131-138
[2]   Inflammation and Alzheimer's disease [J].
Akiyama, H ;
Barger, S ;
Barnum, S ;
Bradt, B ;
Bauer, J ;
Cole, GM ;
Cooper, NR ;
Eikelenboom, P ;
Emmerling, M ;
Fiebich, BL ;
Finch, CE ;
Frautschy, S ;
Griffin, WST ;
Hampel, H ;
Hull, M ;
Landreth, G ;
Lue, LF ;
Mrak, R ;
Mackenzie, IR ;
McGeer, PL ;
O'Banion, MK ;
Pachter, J ;
Pasinetti, G ;
Plata-Salaman, C ;
Rogers, J ;
Rydel, R ;
Shen, Y ;
Streit, W ;
Strohmeyer, R ;
Tooyoma, I ;
Van Muiswinkel, FL ;
Veerhuis, R ;
Walker, D ;
Webster, S ;
Wegrzyniak, B ;
Wenk, G ;
Wyss-Coray, T .
NEUROBIOLOGY OF AGING, 2000, 21 (03) :383-421
[3]  
Andjelkovic AV, 1999, GLIA, V28, P225, DOI 10.1002/(SICI)1098-1136(199912)28:3<225::AID-GLIA6>3.3.CO
[4]  
2-Y
[5]   Intracerebral injection of human immunodeficiency virus type 1 coat protein gp120 differentially affects the expression of nerve growth factor and nitric oxide synthase in the hippocampus of rat [J].
Bagetta, G ;
Corasaniti, MT ;
Aloe, L ;
Berliocchi, L ;
Costa, N ;
FinazziAgro, A ;
Nistico, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (02) :928-933
[6]   Chemokines in pathology and medicine [J].
Baggiolini, M .
JOURNAL OF INTERNAL MEDICINE, 2001, 250 (02) :91-104
[7]   G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator [J].
Bais, C ;
Santomasso, B ;
Coso, O ;
Arvanitakis, L ;
Raaka, EG ;
Gutkind, JS ;
Asch, AS ;
Cesarman, E ;
Gerhengorn, MC ;
Mesri, EA .
NATURE, 1998, 391 (6662) :86-89
[8]   Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1 [J].
Bajetto, A ;
Bonavia, R ;
Barbero, S ;
Piccioli, P ;
Costa, A ;
Florio, T ;
Schettini, G .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (06) :2348-2357
[9]   Chemokines and their receptors in the central nervous system [J].
Bajetto, A ;
Bonavia, R ;
Barbero, S ;
Florio, T ;
Schettini, G .
FRONTIERS IN NEUROENDOCRINOLOGY, 2001, 22 (03) :147-184
[10]   Stromal cell-derived factor-1α induces astrocyte proliferation through the activation of extracellular signal-regulated kinases 1/2 pathway [J].
Bajetto, A ;
Barbero, S ;
Bonavia, R ;
Piccioli, P ;
Pirani, P ;
Florio, T ;
Schettini, G .
JOURNAL OF NEUROCHEMISTRY, 2001, 77 (05) :1226-1236